Drug Guidance for Subsidy 02/05/2019 Rifaximin for reducing recurrent episodes of overt hepatic encephalopathy The Ministry of Health’s Drug Advisory Committee has recommended: Rifaximin 550 mg tablet as... See all × 02/05/2019 Rifaximin for reducing recurrent episodes of overt hepatic encephalopathy The Ministry of Health’s Drug Advisory Committee has recommended: Rifaximin 550 mg tablet as add-on therapy to lactulose for reducing recurrent episodes of overt hepatic encephalopathy. Subsidy status RRifaximin 550 mg tablet is recommended for inclusion on the MOH Standard Drug List (SDL) for the abovementioned indication.
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Tablet 550 mg Alexandra Hospital Changi General Hospital Khoo Teck Puat Hospital Ng Teng Fong General Hospital National University Hospital Sengkang General Hospital Singapore General Hospital Tan Tock Seng Hospital Woodlands Health Campus